Molecular mechanisms underlying the anti-obesity potential of prunetin, an O-methylated isoflavone

Area of Science:

• Biochemistry
• Metabolic research
• Pharmacology

Background:

• Prunetin is an O-methylated isoflavone with limited reported biological activities.
• While in vitro anti-inflammatory effects are known, its anti-adipogenic effects in obese animal models are unexplored.
• Obesity is a growing health concern, necessitating research into novel therapeutic compounds.

Purpose of the Study:

• To investigate the anti-adipogenic effects of prunetin in a high-fat diet (HFD)-induced mouse model of obesity.
• To elucidate the molecular mechanisms underlying prunetin's action on adipogenesis in liver and visceral adipose tissues.
• To assess prunetin's impact on body weight, fat accumulation, and key metabolic gene expression.

Main Methods:

• Mice were fed an HFD for 10 weeks to induce obesity.
• Prunetin was administered at 10 μg/kg or 20 μg/kg during the final 3 weeks.
• Gene expression analysis of adipogenic and lipid metabolism markers (PPARγ, C/EBPα, SREBP, etc.) and protein expression of adipoR1, adipoR2, and AMPK were performed.

Main Results:

• Prunetin treatment significantly reduced body weight gain, visceral fat pad weights, and plasma glucose levels compared to controls.
• Prunetin inhibited the HFD-induced upregulation of adipogenic genes (PPARγ, C/EBPα, SREBP, aP2, LPL, adiponectin, leptin) and lipid metabolism genes (SREBP, PPARγ, LXR, HMG-CoA) in the liver.
• Prunetin increased the expression of adiponectin receptors (adipoR1, adipoR2) and AMP-activated protein kinase (AMPK) in liver and adipose tissue.

Conclusions:

• Prunetin exhibits significant anti-obesity and anti-adipogenic effects in HFD-induced obese mice.
• Prunetin suppresses key adipogenic and lipid metabolism pathways by regulating transcription factors.
• The anti-obesity mechanism involves a feedback loop modulating adiponectin, its receptors, and AMPK signaling.